The role of healthcare providers in HPV vaccination programs – A meeting report

Alex Vorsters*, Paolo Bonanni, Helena C. Maltezou, Joanne Yarwood, Noel T. Brewer, F. Xavier Bosch, Sharon Hanley, Ross Cameron, Eduardo L. Franco, Marc Arbyn, Nubia Muñoz, Mira Kojouharova, Jade Pattyn, Marc Baay, Emilie Karafillakis, Pierre Van Damme

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available.

Original languageEnglish
Article number100183
JournalPapillomavirus Research
Volume8
DOIs
Publication statusPublished - Dec 2019

Bibliographical note

Funding Information:
PB received research funding for epidemiological research and HTA evaluations from MSD, Pfizer, GSK, Sanofi Pasteur and Seqirus, and participated to advisory boards and symposia sponsored by the same companies.

Funding Information:
The University of Antwerp also organizes a Summer School on Vaccinology course3 https://www.uantwerpen.be/en/summer-schools/vaccinology/. for students, including topics on immunology, public health, infectious diseases, vaccines, immunization programs, vaccine safety communication with practical training on how to vaccinate. Finally, the University of Antwerp ? with the support of the Flemish Health Agency - organizes a yearly Valentine Vaccination Symposium4 https://www.uantwerpen.be/nl/onderzoeksgroep/cev/valentijn-vaccinatie/. for vaccinators (doctors and nurses) with scientific presentations covering current vaccination topics relevant to the healthcare sector. In 15 years, the symposium has grown from less than 100 to over 500 participants. To keep the topics as up-to-date as possible, questions are requested from participants beforehand, and answered during the symposium by an expert panel.Finally, training modules are available for HCPs on vaccine safety and contraindications13 http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/2017/training-manual-vaccine-safety-and-false-contraindications-to-vaccination-2017. to prepare confident key trainers and provide training materials to educate front line HCPs. Topics included in the modules are: monitoring of vaccines' safety during pre-and post-licensure periods; WHO recommendations on contraindications and supporting evidence; the basics of AEFI classification and causality assessment; and routine and new vaccines? impact assessment.AV University of Antwerp obtained unrestricted educational grants from GSK, Merck and SPMSD; speakers fees from Merck were paid directly to an educational fund held by the University of Antwerp.NTB has received research grants from and served as a paid consultant for Merck and FDA.FXB received research funding via his institution from GSK, Merck, Qiagen, Roche, and SPMSD, and reimbursement of travel expenses for attending symposia, meetings and/or speaking at conferences from GSK, Merck, Qiagen, Roche, and SPMSD.ELF declares no conflict of interest but discloses that he occasionally serves as advisor for companies involved with HPV diagnostics (Roche) and HPV vaccination (Merck, GSK). His university has received unconditional grants from Roche and Merck for studies that he initiated.MB received medical writing fees from vaccine-producing pharmaceutical companies, including Merck, SPMSD and GSK.EK has received funding through her institution from Merck to convene a research symposium and from Merck and SPMSD for speaking at conferences, symposiums, and meetings.

Funding Information:
NTB has received research grants from and served as a paid consultant for Merck and FDA .

Funding Information:
The HPV Prevention and Control board is supported by in kind contributions and support from the international experts involved and their institutions. To set up the activities, the secretariat obtains unrestricted grants from industry (GlaxoSmithKline Biologicals, Merck, Abbott, Sanofi Pasteur and MSD). All funds are handled according to the rules of the University of Antwerp. No remuneration for experts or speakers is provided.

Publisher Copyright:
© 2019

Fingerprint

Dive into the research topics of 'The role of healthcare providers in HPV vaccination programs – A meeting report'. Together they form a unique fingerprint.

Cite this